Beta BionicsBBNX +1.71%10 Market Cap is $757.6 Mil as of Jul. 07, 2026. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Beta Bionics ranks better than 74.77% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Beta Bionics's share price for the quarter that ended in Mar. 2026 was $10.02. Beta Bionics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 44.6 Mil. Therefore, Beta Bionics's market cap for the quarter that ended in Mar. 2026 was $446.5 Mil.
Beta Bionics's quarterly market cap
increased
from Sep. 2025 ($874.1 Mil) to Dec. 2025 ($1,351.7 Mil) but then
declined
from Dec. 2025 ($1,351.7 Mil) to Mar. 2026 ($446.5 Mil).
Beta Bionics's annual market cap
stayed the same
from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($0.0 Mil) but then
increased
from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($1,351.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beta Bionics's Enterprise Value for Today is $565.0 Mil.
Beta Bionics (NAS:BBNX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Beta Bionics Market Cap Related Terms
Beta Bionics Market Cap Historical Data
* Premium members only.
The historical data trend for Beta Bionics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Beta Bionics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beta Bionics Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beta Bionics's Market Cap distribution charts can be found below:
* The bar in red indicates where Beta Bionics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Beta Bionics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beta Bionics (BBNX) has a Market Cap of $757.6 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beta Bionics and its competitors. According to the industry distribution chart, Beta Bionics ranks #219 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 25.2%.
Is Beta Bionics' Market Cap too high?
Beta Bionics' current Market Cap is $757.6 Mil. The Medical Devices & Instruments industry median Market Cap is 121.35. Beta Bionics' value of $757.6 Mil is 524.3% above this industry median. Based on the distribution chart, Beta Bionics ranks #219 out of 868 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' Market Cap compare to CBLL and SIBN?
According to the Medical Devices & Instruments industry distribution chart, Beta Bionics ranks #219 out of 868 companies for Market Cap. This puts Beta Bionics in the upper half of its industry. The industry median Market Cap is 121.35. Beta Bionics' value of $757.6 Mil is 524.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.35, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beta Bionics's current Market Cap of $757.6 Mil is 524.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beta Bionics and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beta Bionics's current Market Cap is $757.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current Market Cap of $757.6 Mil. The current Market Cap is $757.6 Mil and 524.3% above the Medical Devices & Instruments industry median of 121.35. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Beta Bionics (BBNX), the current Market Cap is $757.6 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score
Get the complete analysis for BBNX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBNX has been successfully added to your 
